Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Generic Exclusivity Awards Process Might Go Public

This article was originally published in The Pink Sheet Daily

Executive Summary

FDA wants to know whether 180-day exclusivity should be revealed up front; question is one of many on ANDA reviews to be considered at September public hearing.

You may also be interested in...



Generic Exclusivity? Who Cares! Industry Offers Few Opinions On Potential Changes

U.S. FDA officials still looking for input after transparency issue not widely addressed during GDUFA policy meeting.

Generic Exclusivity? Who Cares! Industry Offers Few Opinions On Potential Changes

FDA officials still looking for input after transparency issue not widely addressed during GDUFA policy meeting.

ANDA Communication Complaints: FDA Takes Licking, Keeps Ticking

As sponsors vent about uncertain status of their ANDAs, FDA Office of Generic Drugs indicates number of ideas are in process, including providing target action dates for applications without formal review goals.

Related Content

Topics

UsernamePublicRestriction

Register

PS077563

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel